Filing Details
- Accession Number:
- 0001209191-15-087438
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-12-30 19:58:59
- Reporting Period:
- 2015-12-29
- Filing Date:
- 2015-12-30
- Accepted Time:
- 2015-12-30 19:58:59
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1108205 | Curis Inc | CRIS | Biological Products, (No Disgnostic Substances) (2836) | 043505116 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1190121 | R Daniel Passeri | 4 Maguire Road Lexington MA 02421 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2015-12-29 | 11,200 | $1.57 | 210,098 | No | 4 | M | Direct | |
Common Stock | Disposition | 2015-12-29 | 11,200 | $2.91 | 198,898 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2015-12-30 | 14,400 | $1.57 | 213,298 | No | 4 | M | Direct | |
Common Stock | Disposition | 2015-12-30 | 14,400 | $3.01 | 198,898 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Employee stock option | Disposition | 2015-12-29 | 11,200 | $1.57 | 11,200 | $1.57 |
Common Stock | Employee stock option | Disposition | 2015-12-30 | 14,400 | $1.57 | 14,400 | $1.57 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2010-05-31 | 2016-05-31 | No | 4 | M | Direct |
0 | 2010-05-31 | 2016-05-31 | No | 4 | M | Direct |
Footnotes
- These shares were sold between $2.81-$2.99/share pursuant to an effective 10b5-1 plan. The Company will provide, upon request, full information regarding the number of shares sold at each separate price.
- These shares were sold between $2.93-$3.10/share pursuant to an effective 10b5-1 plan. The Company will provide, upon request, full information regarding the number of shares sold at each separate price.
- Options vested over a four-year period and became fully vested on May 31, 2010.